Marapharm Medical Marijuana Investor

Advance Notice Policy

Advance Notice Policy

The purpose of the Policy is to provide shareholders, Directors and Management of the Company with an adequate process for nominating Directors of the Company. This policy is a mechanism, commonly used by public companies, designed to assist the Company in ensuring the fair and equal treatment for all shareholders to engage in the nomination and voting of Directors.

Our Plan

The Policy was approved and adopted by the Board of Directors November 9, 2015. Pursuant to the terms of the Policy, the Company will seek shareholder ratification of the Policy at its next annual general meeting of shareholders in December 2015.

View PDF

MDM on CSE:
thecse.ca
| MRPHF on OTCQB:
otcmarkets.com
| 2M0 (zero) on FSE:
boerse-frankfurt.de